串联闭塞治疗中颈动脉夹层支架置入的安全性与结局
该研究基于TITAN和ETIS两个国际多中心前瞻性观察登记数据库的汇总分析,回顾性分析了2012年1月至2019年1月间24个综合卒中中心收治的136例因夹层导致串联闭塞的急性缺血性卒中患者,其中65例(47.8%)接受急诊颈动脉支架置入(CAS),71例(52.2%)未接受。总体90天良好功能结局(mRS 0-2)率为58.0%,成功再灌注率为77.9%。亚组分析显示CAS组成功再灌注率更高(89.2% vs 67.6%;aOR 2.24 [95%CI 1.33-3.77]),但90天良好结局、症状性颅内出血和90天死亡率均无显著差异;在颅内成功再灌注患者的敏感性分析中,CAS与临床结局改善无关。结论认为急诊支架置入夹层的颈动脉在串联闭塞血管内治疗中似乎是安全的,无论颅内再灌注质量如何。
要点
- 急诊CAS用于夹层相关串联闭塞患者时,成功再灌注率显著提高。
- CAS未显著改善90天良好功能结局、症状性颅内出血或90天死亡率。
- 在颅内成功再灌注患者中,CAS与临床结局改善无关。
核心结论
- 急诊支架置入夹层的颈动脉在串联闭塞血管内治疗中似乎是安全的,无论颅内再灌注质量如何。
研究设计与样本
- 回顾性分析两个前瞻性维护的多中心国际观察性真实世界登记数据库(ETIS和TITAN)的汇总数据。
- 纳入2012年1月至2019年1月间24个综合卒中中心收治的136例因夹层导致串联闭塞并接受血管内治疗的患者。
主要发现
- 总体90天良好功能结局(mRS 0-2)率为58.0%(n=76,95%CI 49.6%-66.5%)。
- 总体成功再灌注(mTICI 2b-3)率为77.9%(n=106,95%CI 71.0%-85.0%)。
- CAS组成功再灌注率89.2% vs 非CAS组67.6%,调整OR 2.24(95%CI 1.33-3.77)。
- CAS组与非CAS组90天良好结局率54.3% vs 61.4%,调整OR 0.84(95%CI 0.58-1.22)。
- 症状性颅内出血率10.8% vs 5.6%,调整OR 1.59(95%CI 0.79-3.17);90天死亡率8.0% vs 5.8%,调整OR 1.00(95%CI 0.48-2.09)。
临床怎么用
- 对于因夹层导致串联闭塞的急性缺血性卒中患者,急诊CAS可考虑用于提高成功再灌注率。
- CAS未显示改善临床结局,决策需权衡再灌注获益与潜在风险。
局限性
- 回顾性研究设计。
- 样本量较小(136例)。
- 仅纳入接受血管内治疗的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The efficacy of endovascular therapy in patients with acute ischemic stroke due to tandem occlusion is comparable to that for isolated intracranial occlusion in the anterior circulation. However, the optimal management of acute cervical internal carotid artery lesions is unknown, especially in the setting of carotid dissection, but emergency carotid artery stenting (CAS) is frequently considered. We investigated the safety and efficacy of emergency CAS for carotid dissection in patients with acute stroke with tandem occlusion in current clinical practice. METHODS: We retrospectively analyzed a prospectively maintained database composed of 2 merged multicenter international observational real-world registries (Endovascular Treatment in Ischemic Stroke and Thrombectomy in Tandem Lesion). Data from endovascular therapy performed in the treatment of tandem occlusions related to acute cervical carotid dissection between January 2012 and January 2019 at 24 comprehensive stroke centers were analyzed. RESULTS: The study assessed 136 patients with tandem occlusion due to dissection, including 65 (47.8%) treated with emergency CAS and 71 (52.2%) without. The overall rates of favorable outcome (90-day modified Rankin Scale score, 0-2) and successful reperfusion (modified Thrombolysis in Cerebral Infarction, 2b-3) were 58.0% (n=76 [95% CI, 49.6%-66.5%]) and 77.9% (n=106 [95% CI, 71.0%-85.0%]), respectively. In subgroup analyses, the rate of successful reperfusion (89.2% versus 67.6%; adjusted odds ratio, 2.24 [95% CI, 1.33-3.77]) was higher after CAS, whereas the 90-day favorable outcome (54.3% versus 61.4%; adjusted odds ratio, 0.84 [95% CI, 0.58-1.22]), symptomatic intracerebral hemorrhage (sICH; 10.8% versus 5.6%; adjusted odds ratio, 1.59 [95% CI, 0.79-3.17]), and 90-day mortality (8.0% versus 5.8%; adjusted odds ratio, 1.00 [95% CI, 0.48-2.09]) did not differ. In sensitivity analyses of patients with successful intracranial reperfusion, CAS was not associated with an improved clinical outcome. CONCLUSIONS: Emergency stenting of the dissected cervical carotid artery during endovascular therapy for tandem occlusions seems safe, whatever the quality of the intracranial reperfusion.
引用
- Marnat G, Lapergue B, Sibon I, et al. Safety and Outcome of Carotid Dissection Stenting During the Treatment of Tandem Occlusions: A Pooled Analysis of TITAN and ETIS. Stroke. 2020. PMID: 33167809. doi:10.1161/STROKEAHA.120.030038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。